BioCryst Pharmaceuticals, Inc. (BMV:BCRX)

BioCryst Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 15, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	24,706	32,457	20,740	41,746	51,090	26,175
Market Cap Growth	-26.15%	56.49%	-50.32%	-18.29%	95.19%	161.10%
Enterprise Value	32,979	43,128	28,311	47,499	53,366	24,930
Last Close Price	118.00	155.00	113.92	215.00	255.00	148.00
PS Ratio	2.25	3.46	3.70	7.90	15.86	73.85
PB Ratio	-3.47	-3.27	-2.69	-7.26	-23.29	-68.29
EV/Sales Ratio	3.13	4.59	5.05	8.99	16.56	70.34
EV/EBITDA Ratio	22.70	1194.32	-	-	-	-
Debt / Equity Ratio	-1.76	-1.77	-1.86	-2.52	-5.54	-14.51
Debt / EBITDA Ratio	8.27	208.58	-	-	-	-
Asset Turnover	1.28	0.90	0.62	0.48	0.34	0.07
Inventory Turnover	29.60	10.11	7.71	12.00	18.93	-
Quick Ratio	1.60	2.49	2.97	4.50	5.18	2.93
Current Ratio	1.87	2.63	3.31	4.89	5.46	3.07
Return on Equity (ROE)	-	-	-	-	-	-1925.37%
Return on Assets (ROA)	10.31%	-0.16%	-11.57%	-16.30%	-24.07%	-41.60%
Return on Capital Employed (ROCE)	30.20%	-0.40%	-26.90%	-33.40%	-36.70%	-74.10%
Earnings Yield	-0.65%	-5.71%	-18.47%	-11.55%	-7.39%	-13.90%
FCF Yield	3.55%	-3.41%	-7.93%	-7.63%	-5.80%	-10.31%
Buyback Yield / Dilution	-1.84%	-7.54%	-3.38%	-3.79%	-7.08%	-44.70%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.